Vulnerability issues in recent onset schizophreniaLEONARD, Brain.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, issn 1359-7868, 60 p.Serial Issue

The course of brain abnormalities in schizophrenia: can we slow the progression?VAN HAREN, N. E; CAHN, W; HULSHOFF POL, H. E et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 8-14, issn 1359-7868, 7 p.Article

Papers presented at the Summer Meeting of the British Association for Psychopharmacology, 24-27 July, 2011, Harrogate, UKJournal of psychopharmacology. Supplement to ... 2011, Vol 25, Num 8, issn 1359-7868, 84 p.Conference Proceedings

Mortality in Schizophrenia - Emerging trends and mechanismsDINAN, Timothy G.Journal of psychopharmacology. Supplement to ... 2010, Vol 24, Num 11, issn 1359-7868, 114 p.Serial Issue

Mortality trends in the general population: the importance of cardiorespiratory fitnessLEE, Duck-Chul; ARTERO, Enrique G; XUEMEI SUI et al.Journal of psychopharmacology. Supplement to ... 2010, Vol 24, Num 11, pp 27-35, issn 1359-7868, 9 p.Article

Remission in depression : definition and initial treatment approachesISRAEL, Joshua A.Journal of psychopharmacology. Supplement to ... 2006, Vol 20, Num 3, pp 5-10, issn 1359-7868, 6 p.Article

Selective serotonin reuptake inhibitors (SSRIs) in depression: a decade ofprogressNUTT, David J; GOLDSTEIN, Burton J.Journal of psychopharmacology. Supplement to ... 1998, Vol 12, Num 3, issn 1359-7868, 111 p.Serial Issue

Nefazodone : structure, mode of action and pharmacokineticsMALIK, K.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 1-4, issn 1359-7868Article

Suicide risk and antidepressant treatmentHENRY, J. A.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 39-40, issn 1359-7868Article

British Association for Psychopharmacology. Summer MeetingJournal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 3, issn 1359-7868, 71 p.Conference Proceedings

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisonsHADDAD, Peter M; DAS, Amlan; KEYHANI, Sarvenaz et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 15-26, issn 1359-7868, 12 p.Article

Examining the effectiveness of antipsychotic medication in first-episode psychosisTAYLOR, Mark; CAVANAGH, Jonathan; HODGSON, Richard et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 27-32, issn 1359-7868, 6 p.Article

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?LEONARD, Brian E; SCHWARZ, Markus; AYE MU MYINT et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 33-41, issn 1359-7868, 9 p.Article

A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implicationsBEARY, Michael; HODGSON, Richard; WILDGUST, Hiram J et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 52-61, issn 1359-7868, 10 p.Article

BRITISH ASSOCIATION FOR PSYCHOPHARMACOLOGY, 25 - 28 July, Harrogate, UKJournal of psychopharmacology. Supplement to ... 2010, Vol 24, Num 3, issn 1359-7868, 93 p.Conference Proceedings

Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?JOSEPH WILDGUST, Hiram; BEARY, Mike.Journal of psychopharmacology. Supplement to ... 2010, Vol 24, Num 11, pp 37-50, issn 1359-7868, 14 p.Article

Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysisMITCHELL, Alex J; LORD, Oliver.Journal of psychopharmacology. Supplement to ... 2010, Vol 24, Num 11, pp 69-80, issn 1359-7868, 12 p.Article

Proceedings of a satellite symposium held at the Xth Congress of the European Sleep Research Society, 8 September 1998, Madrid, SpainNUTT, D. J; DOBLE, A.Journal of psychopharmacology. Supplement to ... 1999, Vol 13, Num 1, issn 1359-7868, 40 p.Conference Proceedings

Selective serotonin reuptake inhibitors in affective disorders - I. Basic pharmacologyGOODNICK, P. J; GOLDSTEIN, B. J.Journal of psychopharmacology. Supplement to ... 1998, Vol 12, Num 3, pp S5-S20, issn 1359-7868Article

Efficacy of nefazodone in the treatment of depressionMONTGOMERY, S. A.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 5-10, issn 1359-7868Article

Safety and tolerability profile of nefazodoneMARCUS, R. N.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 11-17, issn 1359-7868Article

Tricyclic antidepressants : effective, cheap but are they safe ?LEONARD, B. E.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 35-38, issn 1359-7868Article

Depression and sexual functionBALDWIN, D. S.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 30-34, issn 1359-7868Article

Depression : considerations for treatment of a recurrent and chronic disorderKELLER, M. B.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 41-44, issn 1359-7868Article

Effect of nefazodone and lithium on sleep architecture in healthy menSHARPLEY, A. L; WALSH, A. E. S; COWEN, P. J et al.Journal of psychopharmacology. Supplement to ... 1996, Vol 10, Num 1, pp 26-29, issn 1359-7868Article